In vivo synergism of roxithromycin (RU 965) and interferon against Toxoplasma gondii.

We investigated the activity of roxithromycin (RU 965) and gamma interferon alone and in combination in a murine model of toxoplasmic encephalitis. Roxithromycin at a dosage of 35 or 50 mg per mouse per day decreased mortality. Gamma interferon alone significantly prolonged time to death. When combi...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Hofflin, J M, Remington, J S
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1987
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174724/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3105452/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.2.346
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!